Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

894 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.
Serebruany V, Sani Y, Eisert C, Schevchuck A, Fong A, Hanley D. Serebruany V, et al. Among authors: hanley d. Thromb Haemost. 2011 Jan;105(1):81-7. doi: 10.1160/TH10-05-0316. Epub 2010 Oct 26. Thromb Haemost. 2011. PMID: 20978715 Clinical Trial.
Noncompliance in antiplatelet trials: the AGATE trial perspective.
Serebruany VL, Hanley DF Jr, Atar D, Ferguson JJ. Serebruany VL, et al. Among authors: hanley df jr. Stroke. 2004 Jun;35(6):e143. doi: 10.1161/01.STR.0000126037.53283.30. Epub 2004 Apr 15. Stroke. 2004. PMID: 15087566 No abstract available.
Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation.
Serebruany VL, Fortmann SD, Rao SV, Tanguay JF, Lordkipanidze M, Hanley DF, Can M, Kim MH, Marciniak TA. Serebruany VL, et al. Among authors: hanley df. Thromb Haemost. 2016 May 2;115(5):905-10. doi: 10.1160/TH15-11-0882. Epub 2016 Feb 18. Thromb Haemost. 2016. PMID: 26887783 Review.
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Serebruany VL, et al. Clin Ther. 2008 Feb;30(2):249-59. doi: 10.1016/j.clinthera.2008.02.006. Clin Ther. 2008. PMID: 18343263 Clinical Trial.
894 results